查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571550

人工授精市場規模、佔有率、趨勢分析報告：按類型、按來源、按最終用途、按地區、細分市場預測，2024-2030 年

Artificial Insemination Market Size, Share & Trends Analysis Report By Type (Intrauterine, Intracervical, Intravaginal, Intratubal), By Source Outlook, By End Use (AIH-Husband And AID-Donor), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

人工授精市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球人工授精市場規模將達到40.1億美元，2024年至2030年複合年成長率為8.6%。

近年來，不孕症已成為全球重大的公共衛生問題。人工授精通常是解決不孕症的第一線治療方法。生活方式的改變、受孕延遲和荷爾蒙問題導致不孕症相關問題的增加。根據聯合國預測，到2050年，全球出生率預計將下降至2.2%。在開發中國家和低度開發國家，有關不孕症的醫療諮詢並不容易。

導致人們對人工授精、捐贈者人工授精、體外受精等輔助生殖技術缺乏認知。人工授精的平均費用約為865美元。每個週期的成功率為4-5%，使用促排卵藥物可提高至7-16%。然而，不建議老年女性進行子宮腔內人工授精（IUI），因為成功的機會較低，並且可能會導致進一步的併發症。人工授精可以解決一些不孕問題，例如精液過敏、不明原因不孕和性行為感染傳染病（STD）。

人工授精市場報告亮點

  • 2023 年宮內人工授精 (IUI) 佔據市場主導地位，銷售佔有率為 71.7%。這是因為其手術相對簡單、侵入性極小並且能夠有效治療各種不孕問題。
  • AIH-Husband在2023年佔了66.8%的銷售佔有率。這是由於面臨不孕症挑戰的夫妻對輔助生殖技術的認知和接受程度不斷提高。
  • 2023 年，生育診所和其他機構以 53.2% 的佔有率主導市場。這些診所提供受控環境，由經驗豐富的醫療專業人員進行治療，以最大限度地提高治療效果。
  • 2023年亞太人工授精市場佔30.1%佔有率。這一成長歸因於不孕夫婦數量的增加和不孕不育治療領域的技術進步。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章人工授精市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 人工授精市場分析工具
    • 波特的分析
    • PESTEL分析

第4章人工授精市場：依類型估價與趨勢分析

  • 細分儀表板
  • 人工授精市場：2023 年和 2030 年按類型分類的波動分析
  • 子宮腔內人工授精
  • 子宮頸內人工授精
  • 陰道內人工授精
  • 輸卵管內授精

第5章 人工授精市場：依來源估算與趨勢分析

  • 細分儀表板
  • 人工授精市場：2023年及2030年依來源變化分析
  • 人工授精
  • 非配偶間的人工授精

第6章人工授精市場：最終用途的估計與趨勢分析

  • 細分儀表板
  • 人工授精市場：2023 年和 2030 年最終用途的變化分析
  • 生育診所和其他設施
  • 家用

第7章人工授精市場：依地區估價及趨勢分析

  • 人工授精市場佔有率：依地區分類，2023 年及 2030 年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Vitrolife
    • Genea Pty Limited
    • Rinovum Women's Health, LLC
    • Pride Angel
    • HI-TECH SOLUTIONS
    • FUJIFILM Irvine Scientific
    • Kitazato Corporation
    • Rocket Medical plc
    • Conceivex, Inc.
簡介目錄
Product Code: GVR-2-68038-176-4

Artificial Insemination Market Growth & Trends:

The global artificial insemination market size is expected to reach USD 4.01 billion by 2030 registering a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.

Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).

Artificial Insemination Market Report Highlights:

  • Intrauterine insemination (IUI) dominated the market with 71.7% of revenue share in 2023. This is due to its relatively simple procedure, minimal invasiveness, and effectiveness in treating various infertility issues.
  • AIH-Husband dominated the market with 66.8% of revenue share in 2023. This is due to the increasing awareness and acceptance of assisted reproductive technologies among couples facing infertility challenges.
  • Fertility clinics & others dominated the market with 53.2% share in 2023. These clinics offer a controlled environment with experienced medical professionals to perform the procedure, maximizing its effectiveness.
  • Asia Pacific artificial insemination market dominated the market with 30.1% share in 2023. This growth is attributed to the rising number of infertile couples and technological advancements in the fertility segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Insemination Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Artificial Insemination Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Artificial Insemination Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Artificial Insemination Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Intrauterine Insemination
    • 4.3.1. Intrauterine Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Intracervical Insemination
    • 4.4.1. Intracervical Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Intravaginal Insemination
    • 4.5.1. Intravaginal Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Intratubal Insemination
    • 4.6.1. Intratubal Insemination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Artificial Insemination Market: Source Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Artificial Insemination Market: Source Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. AIH-Husband
    • 5.3.1. AIH-Husband Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. AID-Donor
    • 5.4.1. AID-Donor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Artificial Insemination Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Artificial Insemination Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Fertility Clinics & Other Facilities
    • 6.3.1. Fertility clinics & other facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Home
    • 6.4.1. Home Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Artificial Insemination Market: Regional Estimates & Trend Analysis

  • 7.1. Artificial Insemination Market Share, By Region, 2023 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Artificial Insemination Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Vitrolife
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Genea Pty Limited
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Rinovum Women's Health, LLC
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Pride Angel
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. HI-TECH SOLUTIONS
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. FUJIFILM Irvine Scientific
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Kitazato Corporation
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Rocket Medical plc
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Conceivex, Inc.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives